Off-Label Use of Atypical Antipsychotics: An Update
Introduction to Atypical Antipsychotics (2 of 4)
As of the date of this review, nine second-generation, atypical antipsychotic drugs have been approved by the U.S. Food and Drug Administration (FDA).
Clozapine (Clozaril®, FazaClo®)
Keywords: aripiprazole | asenapine | atypical antipsychotics | clozapine | iloperidone | off-label | olanzapine | paliperidone | quetiapine | risperidone | second generation | ziprasidone | antipsychotics
- Maglione M, Ruelaz Maher A, Hu J, et al. Off-Label Use of Atypical Antipsychotics: An Update. Comparative Effectiveness Review No. 43 (Prepared by the Southern California RAND Evidence-based Practice Center under Contract No. HHSA 290-2007-10062-I). Rockville, MD: Agency for Healthcare Research and Quality; September 2011. AHRQ Publication No. 11(12)-EHC087-EF. Available at www.effectivehealthcare.ahrq.gov/offlabelantipsych.cfm.
Your slide tray is being processed.